| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1269-1278, Copyright © 1995 by Endocrine Society
ARTICLES |
C Lee, MD Luck, H Juppner, JT Potts Jr, HM Kronenberg and TJ Gardella
Endocrine Unit, Massachusetts General Hospital, Boston 02114, USA.
To identify determinants in the rat PTH receptor critical for binding the agonist peptide, PTH-(1-34), we systematically replaced 12 segments (5-33 residues) of the receptor's extracellular surface with the corresponding segments of the homologous rat secretin receptor and screened the resulting mutants in COS-7 cells for altered PTH-(1-34) binding properties. Surface expression of mutant receptors was assessed by the binding of monoclonal antibody 12CA5 to the epitope (HA)-tagged receptors. Of the nine well expressed and therefore informative receptor mutants, four bound radiolabeled PTH-(1-34) at levels that were proportional to the corresponding levels of surface expression, whereas five mutants bound [125I]PTH-(1-34) to levels that were lower than predicted from the cell surface expression levels. These five mutations occurred at the extracellular (EC) end of transmembrane domain 1, the carboxy-terminal portion of the first EC loop, the second EC loop, and the third EC loop. We selected for further fine structure analysis the third EC loop; two specific residues, Trp-437 and Gln-440, were identified at which mutations caused 9- to 16-fold reductions in PTH-(1-34)-binding affinity. The same mutations had little or no effect on the binding affinity of PTH-(3-34). This study provides new information on the location of PTH receptor regions important for high affinity agonist binding and identifies two residues in the third extracellular loop which may contribute to interactions involving the hormone's critical amino terminus.
This article has been cited by other articles:
![]() |
T. M. Murray, L. G. Rao, P. Divieti, and F. R. Bringhurst Parathyroid Hormone Secretion and Action: Evidence for Discrete Receptors for the Carboxyl-Terminal Region and Related Biological Actions of Carboxyl- Terminal Ligands Endocr. Rev., February 1, 2005; 26(1): 78 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor J. Biol. Chem., July 23, 2004; 279(30): 31177 - 31182. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dong, Z. Li, D. I. Pinon, T. P. Lybrand, and L. J. Miller Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor J. Biol. Chem., January 23, 2004; 279(4): 2894 - 2903. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Gensure, N. Shimizu, J. Tsang, and T. J. Gardella Identification of a Contact Site for Residue 19 of Parathyroid Hormone (PTH) and PTH-Related Protein Analogs in Transmembrane Domain Two of the Type 1 PTH Receptor Mol. Endocrinol., December 1, 2003; 17(12): 2647 - 2658. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimada, X. Chen, T. Cvrk, H. Hilfiker, M. Parfenova, and G. V. Segre Purification and Characterization of a Receptor for Human Parathyroid Hormone and Parathyroid Hormone-related Peptide J. Biol. Chem., August 23, 2002; 277(35): 31774 - 31780. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Dautzenberg, J. Higelin, O. Brauns, B. Butscha, and R. L. Hauger Five Amino Acids of the Xenopus laevis CRF (Corticotropin-Releasing Factor) Type 2 Receptor Mediate Differential Binding of CRF Ligands in Comparison with Its Human Counterpart Mol. Pharmacol., May 1, 2002; 61(5): 1132 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Gensure, P. H. Carter, B. D. Petroni, H. Juppner, and T. J. Gardella Identification of Determinants of Inverse Agonism in a Constitutively Active Parathyroid Hormone/Parathyroid Hormone-related Peptide Receptor by Photoaffinity Cross-linking and Mutational Analysis J. Biol. Chem., November 9, 2001; 276(46): 42692 - 42699. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Goold, T. B. Usdin, and S. R. J. Hoare Regions in Rat and Human Parathyroid Hormone (PTH) 2 Receptors Controlling Receptor Interaction with PTH and with Antagonist Ligands J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 678 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-P. Vilardaga, I. Lin, and R. A. Nissenson Analysis of Parathyroid Hormone (PTH)/Secretin Receptor Chimeras Differentiates the Role of Functional Domains in the PTH/ PTH-Related Peptide (PTHrP) Receptor on Hormone Binding and Receptor Activation Mol. Endocrinol., July 1, 2001; 15(7): 1186 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. Carter, M. Shimizu, M. D. Luck, and T. J. Gardella The Hydrophobic Residues Phenylalanine 184 and Leucine 187 in the Type-1 Parathyroid Hormone (PTH) Receptor Functionally Interact with the Amino-terminal Portion of PTH-(1-34) J. Biol. Chem., November 5, 1999; 274(45): 31955 - 31960. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mannstadt, H. Juppner, and T. J. Gardella Receptors for PTH and PTHrP: their biological importance and functional properties Am J Physiol Renal Physiol, November 1, 1999; 277(5): F665 - F675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. J. Hoare, G. de Vries, and T. B. Usdin Measurement of Agonist and Antagonist Ligand-Binding Parameters at the Human Parathyroid Hormone Type 1 Receptor: Evaluation of Receptor States and Modulation by Guanine Nucleotide J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1323 - 1333. [Abstract] [Full Text] |
||||
![]() |
M. D. Luck, P. H. Carter, and T. J. Gardella The (1-14) Fragment of Parathyroid Hormone (PTH) Activates Intact and Amino-Terminally Truncated PTH-1 Receptors Mol. Endocrinol., May 1, 1999; 13(5): 670 - 680. [Abstract] [Full Text] |
||||
![]() |
A. E. Adams, A. Bisello, M. Chorev, M. Rosenblatt, and L. J. Suva Arginine 186 in the Extracellular N-Terminal Region of the Human Parathyroid Hormone 1 Receptor Is Essential for Contact with Position 13 of the Hormone Mol. Endocrinol., November 1, 1998; 12(11): 1673 - 1683. [Abstract] [Full Text] |
||||
![]() |
L. Y. Xie and A. B. Abou-Samra Epitope Tag Mapping of the Extracellular and Cytoplasmic Domains of the Rat Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Endocrinology, November 1, 1998; 139(11): 4563 - 4567. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bisello, A. E. Adams, D. F. Mierke, M. Pellegrini, M. Rosenblatt, L. J. Suva, and M. Chorev Parathyroid Hormone-Receptor Interactions Identified Directly by Photocross-linking and Molecular Modeling Studies J. Biol. Chem., August 28, 1998; 273(35): 22498 - 22505. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mannstadt, M. D. Luck, T. J. Gardella, and H. Juppner Evidence for a Ligand Interaction Site at the Amino-Terminus of the Parathyroid Hormone (PTH)/PTH-related Protein Receptor from Cross-linking and Mutational Studies J. Biol. Chem., July 3, 1998; 273(27): 16890 - 16896. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. DeAlmeida and K. E. Mayo Identification of Binding Domains of the Growth Hormone-Releasing Hormone Receptor by Analysis of Mutant and Chimeric Receptor Proteins Mol. Endocrinol., May 1, 1998; 12(5): 750 - 765. [Abstract] [Full Text] |
||||
![]() |
J. A. Clark, T. I. Bonner, A. S. Kim, and T. B. Usdin Multiple Regions of Ligand Discrimination Revealed by Analysis of Chimeric Parathyroid Hormone 2 (PTH2) and PTH/PTH-Related Peptide (PTHrP) Receptors Mol. Endocrinol., February 1, 1998; 12(2): 193 - 206. [Abstract] [Full Text] |
||||
![]() |
C. Bergwitz, S. A. Jusseaume, M. D. Luck, H. Juppner, and T. J. Gardella Residues in the Membrane-spanning and Extracellular Loop Regions of the Parathyroid Hormone (PTH)-2 Receptor Determine Signaling Selectivity for PTH and PTH-related Peptide J. Biol. Chem., November 14, 1997; 272(46): 28861 - 28868. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, C. A. Dennis, G. R. Moore, R. James, and C. Kleanthous Protein-Protein Interaction Specificity of Im9 for the Endonuclease Toxin Colicin E9 Defined by Homologue-scanning Mutagenesis J. Biol. Chem., August 29, 1997; 272(35): 22253 - 22258. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hashimoto, N. Ogawa, N. Hagihara, K. Yamamoto, K. Imanishi, H. Nogi, A. Nishino, T. Fujita, T. Matsuda, S. Nagata, et al. Vasoactive Intestinal Polypeptide and Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Chimeras Reveal Domains That Determine Specificity of Vasoactive Intestinal Polypeptide Binding and Activation Mol. Pharmacol., July 1, 1997; 52(1): 128 - 135. [Abstract] [Full Text] |
||||
![]() |
A. T. Zhou, R. Bessalle, A. Bisello, C. Nakamoto, M. Rosenblatt, L. J. Suva, and M. Chorev Direct mapping of an agonist-binding domain within the parathyroid hormone/parathyroid hormone-related protein receptor by photoaffinity crosslinking PNAS, April 15, 1997; 94(8): 3644 - 3649. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bergwitz, T. J. Gardella, M. R. Flannery, J. T. Potts Jr., H. M. Kronenberg, S. R. Goldring, and H. Juppner Full Activation of Chimeric Receptors by Hybrids between Parathyroid Hormone and Calcitonin. EVIDENCE FOR A COMMON PATTERN OF LIGAND-RECEPTOR INTERACTION J. Biol. Chem., October 25, 1996; 271(43): 26469 - 26472. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gardella, M. D. Luck, G. S. Jensen, T. B. Usdin, and H. Juppner Converting Parathyroid Hormone-related Peptide (PTHrP) into a Potent PTH-2 Receptor Agonist J. Biol. Chem., August 16, 1996; 271(33): 19888 - 19893. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Azarani, D. Goltzman, and J. Orlowski Structurally Diverse N-terminal Peptides of Parathyroid Hormone (PTH) and PTH-related Peptide (PTHRP) Inhibit the Na+/H+ Exchanger NHE3 Isoform by Binding to the PTH/PTHRP Receptor Type I and Activating Distinct Signaling Pathways J. Biol. Chem., June 21, 1996; 271(25): 14931 - 14936. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Gardella, M. D. Luck, M.-H. Fan, and C. Lee Transmembrane Residues of the Parathyroid Hormone (PTH)/PTH-related Peptide Receptor That Specifically Affect Binding and Signaling by Agonist Ligands J. Biol. Chem., May 31, 1996; 271(22): 12820 - 12825. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, P. H. Carter, and T. J. Gardella Autoactivation of Type-1 Parathyroid Hormone Receptors Containing a Tethered Ligand J. Biol. Chem., June 23, 2000; 275(26): 19456 - 19460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. J. Hoare, J. A. Clark, and T. B. Usdin Molecular Determinants of Tuberoinfundibular Peptide of 39 Residues (TIP39) Selectivity for the Parathyroid Hormone-2 (PTH2) Receptor. N-TERMINAL TRUNCATION OF TIP39 REVERSES PTH2 RECEPTOR/PTH1 RECEPTOR BINDING SELECTIVITY J. Biol. Chem., August 25, 2000; 275(35): 27274 - 27283. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Gensure, T. J. Gardella, and H. Juppner Multiple Sites of Contact between the Carboxyl-terminal Binding Domain of PTHrP-(1-36) Analogs and the Amino-terminal Extracellular Domain of the PTH/PTHrP Receptor Identified by Photoaffinity Cross-linking J. Biol. Chem., July 27, 2001; 276(31): 28650 - 28658. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Shimizu, J. Guo, and T. J. Gardella Parathyroid Hormone (PTH)-(1-14) and -(1-11) Analogs Conformationally Constrained by alpha -Aminoisobutyric Acid Mediate Full Agonist Responses via the Juxtamembrane Region of the PTH-1 Receptor J. Biol. Chem., December 21, 2001; 276(52): 49003 - 49012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Shimizu, J. T. Potts Jr., and T. J. Gardella Minimization of Parathyroid Hormone. NOVEL AMINO-TERMINAL PARATHYROID HORMONE FRAGMENTS WITH ENHANCED POTENCY IN ACTIVATING THE TYPE-1 PARATHYROID HORMONE RECEPTOR J. Biol. Chem., July 14, 2000; 275(29): 21836 - 21843. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |